Covered recipient · General Payments record
BAHADOR MOMENI
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$1,012.91
- Reported across 48 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $428.91 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $85.23 | 4 |
| Abbott Laboratories | $79.04 | 4 |
| PFIZER INC. | $60.06 | 2 |
| BSN Medical Inc | $39.92 | 1 |
| GlaxoSmithKline, LLC. | $34.13 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $33.13 | 1 |
| ABBVIE INC. | $25.93 | 1 |
| Astellas Pharma US Inc | $25.21 | 1 |
| Corcept Therapeutics | $25.05 | 1 |
| Exact Sciences Corporation | $21.21 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $13.64 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124876090 | CMS |
| Abbott Laboratories | $19.96 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124876092 | CMS |
| Abbott Laboratories | $22.74 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124876094 | CMS |
| Abbott Laboratories | $22.70 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124876096 | CMS |
| ABBVIE INC. | $25.93 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105054568 | CMS |
| Astellas Pharma US Inc | $25.21 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139434314 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $33.13 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086179016 | CMS |
| BSN Medical Inc | $39.92 | 07/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1123333138 | CMS |
| Corcept Therapeutics | $25.05 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117766507 | CMS |
| Exact Sciences Corporation | $21.21 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114793795 | CMS |
| GlaxoSmithKline, LLC. | $18.25 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115929065 | CMS |
| GlaxoSmithKline, LLC. | $15.88 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116608478 | CMS |
| Novo Nordisk Inc | $20.15 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097408348 | CMS |
| Novo Nordisk Inc | $17.01 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096888858 | CMS |
| Novo Nordisk Inc | $21.59 | 11/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097672337 | CMS |
| Novo Nordisk Inc | $26.48 | 12/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096622174 | CMS |
| PFIZER INC. | $33.18 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132100697 | CMS |
| PFIZER INC. | $26.88 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131468826 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.